Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.000
+0.004 (0.40%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $6.41 million as of October 31, 2024. Its market cap has increased by 77.94% in one year.
Market Cap
6.41M
Enterprise Value
3.09M
1-Year Change
77.94%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.30M to $6.41M, a decrease of -75.64%. That is a compound annual growth rate of -20.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 6.40M | 178.26% |
Dec 29, 2023 | 2.30M | -60.34% |
Dec 30, 2022 | 5.80M | -89.66% |
Dec 31, 2021 | 56.10M | 131.82% |
Dec 31, 2020 | 24.20M | -2.81% |
Dec 31, 2019 | 24.90M | -25.89% |
Dec 31, 2018 | 33.60M | 27.76% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Healthcare Triangle | 6.86M |
Organovo Holdings | 6.84M |
CNS Pharmaceuticals | 6.83M |
Hoth Therapeutics | 6.73M |
Forte Biosciences | 6.69M |
Intelligent Bio Solutions | 6.46M |
Portage Biotech | 6.24M |
SunLink Health Systems | 6.20M |